8F5Q
Crystal structure of human PCNA in complex with the PIP box of FBH1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2022-03-17 |
Detector | RDI CMOS_8M |
Wavelength(s) | 1.28 |
Spacegroup name | I 1 2 1 |
Unit cell lengths | 81.950, 82.210, 118.558 |
Unit cell angles | 90.00, 91.26, 90.00 |
Refinement procedure
Resolution | 41.790 - 1.900 |
R-factor | 0.2254 |
Rwork | 0.224 |
R-free | 0.26620 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5iy4 |
RMSD bond length | 0.013 |
RMSD bond angle | 2.260 |
Data reduction software | iMOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.18.2_3874) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 41.790 | 1.968 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.043 | |
Number of reflections | 62010 | 11431 |
<I/σ(I)> | 9 | |
Completeness [%] | 98.3 | |
Redundancy | 1.9 | |
CC(1/2) | 0.997 | 0.567 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 298 | 0.1 M HEPES, pH 7.5, 0.2 M magnesium chloride, 30% PEG400 |